Seminars in Nuclear Medicine
Volume 35, Issue 1 , Pages 2-16 , January 2005

Assessment of myocardial viability

  • Mark I. Travin, MD

      Affiliations

    • Department of Nuclear Medicine, Montefiore Medical Center, Beth Israel Medical Center, Bronx, NY.
    • Corresponding Author InformationAddress reprint requests to Mark I. Travin, MD, Department of Nuclear Medicine, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467-2490.
    • ,
  • Steven R. Bergmann, MD, PhD

      Affiliations

    • Division of Cardiology, Beth Israel Medical Center, New York, NY.

References 

  1. Gheorgiade M , Bonow RO . Chronic heart failure in the United States. A manifestation of coronary artery disease . Circulation . 1998;97:282–289
  2. Abraham WT , Bristow MR . Specialized centers for heart failure management . Circulation . 1997;96:2755–2757
  3. The SOLVD investigators . Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure . N Engl J Med . 1991;325:293–302
  4. Pitt B , Poole-Wilson PA , Segal R , et al.   Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure (Randomized trial—The Losartan Heart Failure Study ELITE II) . Lancet . 2000;355:1582–1587
  5. Cohn JN , Archibald DG , Ziesche S , et al.   Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study . N Engl J Med . 1986;314:1547–1552
  6. Packer M , Fowler MB , Roecker EB , et al.   Effect of carvedilol on the morbidity of patients with severe chronic heart failure (Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study) . Circulation . 2002;106:2194–2199
  7. Pitt B , Zannad F , Remme WJ  randomized aldactone evaluation study investigators . The effect of spironolactone on morbidity and mortality in patients with severe heart failure . N Engl J Med . 1999;341:709–717
  8. Colucci WS , Elkayam U , Horton DP , et al.  Nesiritide Study Group   Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure . N Engl J Med . 2000;343:246–253
  9. Abraham WT , Hayes DL . Cardiac resynchronization therapy for heart failure . Circulation . 2003;108:2596–2603
  10. Deedwania PC . The key to unraveling the mystery of mortality in heart failure. An integrated approach . Circulation . 2003;107:1719–1721
  11. Dilsizian V . Myocardial viability (Reversible left ventricular dysfunction) . In:  Dilsizian V ,  Narula J ,  Braunwald E editor. Atlas of Nuclear Cardiology . Philadelphia, PA: Current Medicine; 2003;p. 19–46
  12. Kloner RA , Bolli R , Marban E , et al.   Medical and cellular implications of stunning, hibernation, and preconditioning. An NHLBI workshop . Circulation . 1998;97:1848–1867
  13. Topol EJ , Weiss JL , Brinker JA , et al.   Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator (Importance of coronary angioplasty) . J Am Coll Cardiol . 1985;6:426–433
  14. Schwaiger M , Schricke U . Hibernating and stunned myocardium. Pathophysiological considerations . In:  Iskandrian AE ,  Van Der Wall EE editor. Myocardial Viability . ed 2. Dordrecht, Boston, London: Kluwer Academic Publishers; 2000;p. 1–20
  15. Rahimtoola SH . The hibernating myocardium . Am Heart J . 1989;117:211–221
  16. Rahimtoola S . Coronary bypass surgery for chronic angina—1981 (A perspective) . Circulation . 1982;65:225–241
  17. Canty JM , Fallavolita JA . Resting myocardial flow in hibernating myocardium (Validating animal models of human pathophysiology) . Am J Physiol . 1999;276:H417; (abstract)
  18. Vanoverschelde JLJ , Wijins W , Depre C , et al.   Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium . Circulation . 1993;87:1513–1523
  19. Bax JJ , Wahba FF , Van Der Waal EE . Myocardial viability/hibernation . In:  Iskandrian AE ,  Verani MS editor. Nuclear Cardiac Imaging . New York: Oxford University Press; 2003;p. 386–398
  20. Baliga RR , Schaper J , Narula JP . Role of apoptosis in myocardial hibernation and myocardial stunning . In:  Iskandrian AE ,  Van Der Wall EE editor. Myocardial Viability . ed 2. Dordrecht, Boston, London: Kluwer Academic Publishers; 2000;p. 21–45
  21. Lim ETS , Lahiri A , et al.   Should we be screening for myocardial hibernation in heart failure? . J Nucl Cardiol . 2004;11:114–117
  22. Cleland JG , Pennell DJ , Ray SG , et al.   Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial) (Randomised controlled trial) . Lancet . 2003;362:14–21
  23. DiCarli M . Assessment of myocardial viability after myocardial infarction . J Nucl Cardiol . 2002;9:229–235
  24. Beanlands RS , Hendry PJ , Masters RG , et al.   Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging . Circulation . 1998;98:1151–1156
  25. Emond M , Mock M , Davis K , et al.   Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry . Circulation . 1994;90:2645–2657
  26. Gioia G , Milan E , Giubbini R , et al.   Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction . J Nucl Cardiol . 1996;3:150–156
  27. DiCarli MF , Davidson M , Little R , et al.   Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction . Am J Cardiol . 1994;73:527–533
  28. Allman KC , Shaw LJ , Hachamovitch R , et al.   Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction (A meta-analysis) . J Am Coll Cardiol . 2002;39:1151–1158
  29. Haas F , Haehnel CJ , Picker W , et al.   Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease . J Am Coll Cardiol . 1997;30:1693–1700
  30. Bax JJ , Poldermans D , Elhendy A , et al.   Sensitivity, specificity, and predictive accuracy of various noninvasive techniques for detecting hibernating myocardium . Curr Probl Cardiol . 2001;26:141–188
  31. Lebowitz E , Greene MW , Fairchild R , et al.   Thallium-201 for medical use. I . J Nucl Med . 1975;16:151–155
  32. Pohost GM , Zir LM , Moore RH , et al.   Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201 . Circulation . 1977;55:294–302
  33. Gutman J , Berman DS , Freeman M , et al.   Time to completed redistribution of thallium-201 in exercise myocardial scintigraphy (Relationship to the degree of coronary artery stenosis) . Am Heart J . 1983;106:989–995
  34. Kiat H , Berman DS , Maddahi J , et al.   Late reversibility of tomographic myocardial thallium-201 defects (an accurate marker of myocardial viability) . J Am Coll Cardiol . 1988;12:1456–1463
  35. Liu P , Kiess MC , Okada RD , et al.   The persistent defect on exercise thallium imaging and its fate after myocardial revascularization (Does it represent scar or ischemia?) . Am Heart J . 1985;110:996–1001
  36. Gibson RS , Watson DD , Taylor GJ , et al.   Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy . J Am Coll Cardiol . 1983;1:804–815
  37. Tillisch J , Brunken R , Marshall R , et al.   Reversibility of cardiac wall-motion abnormalities predicted by positron tomography . N Engl J Med . 1986;314:884–888
  38. Brunken R , Schwaiger M , Grover-McKay M , et al.   Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects . J Am Coll Cardiol . 1987;10:557–567
  39. Dilsizian V , Rocco TP , Freedman NMT , et al.   Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging . N Engl J Med . 1990;323:141–146
  40. Bonow RO , Dilsizian V , Cuocolo A , et al.   Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose . Circulation . 1991;83:26–37
  41. Berger BC , Watson DD , Burwell LR , et al.   Redistribution of thallium at rest in patients with stable and unstable angina and the effect of coronary artery bypass surgery . Circulation . 1979;60:1114–1125
  42. Iskandrian AS , Hakki A , Kane SA , et al.   Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting . Am J Cardiol . 1983;51:1312–1316
  43. Ragosta M , Beller GA , Watson DD , et al.   Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function . Circulation . 1993;87:1630–1641
  44. Pagley PR , Beller GA , Watson DD , et al.   Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability . Circulation . 1997;96:793–800
  45. Sciagrà R , Bisi G , Santoro GM , et al.   Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting post-revascularization recovery . J Am Coll Cardiol . 1997;30:384–391
  46. Kitsiou AN , Srinivasan G , Quyyumi AA , et al.   Stress-induced reversible and mild-moderate irreversible thallium defects (Are they equally accurate for predicting recovery of regional left ventricular function after revascularization?) . Circulation . 1998;98:501–508
  47. Klocke FJ, Baird MG, Bateman TM, et al: ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Radionuclide Imaging). (2003). American College of Cardiology Web Site. Available at http://www.acc.org/clinical/guidelines/radio/rni_fulltext.pdf; Internet; accessed September 30, 2004
  48. Taillefer R , DePuey EG , Udelson JE , et al.   Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-Gated SPECT) in detecting coronary artery disease in women . J Am Coll Cardiol . 1997;29:69–77
  49. Miller DD . The growing flood of technetium-99m myocardial perfusion agents. More water … or more mud? . Circulation . 1995;91:555–558
  50. Cohen MC . A snapshot of nuclear cardiology in the United States . Am Soc Nucl Cardiol Newsletter . 1998;5:13
  51. Cuocolo A , Pace L , Ricciardelli B , et al.   Identification of viable myocardium in patients with chronic coronary artery disease (Comparison of thallium-201 scintigraphy with reinjection and technetium-99m methoxyisobutyl isonitrile) . J Nucl Med . 1992;33:505–511
  52. Marzullo P , Sambuceti G , Parodi O . The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability . J Nucl Med . 1992;33:1925–1930
  53. Marcassa C , Galli M , Cuocolo A , et al.   Rest-redistribution thallium-201 and rest technetium-99m-sestamibi SPECT in patients with stable coronary artery disease and ventricular dysfunction . J Nucl Med . 1997;38:419–424
  54. Udelson JE , Coleman PS , Metherall J , et al.   Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi . Circulation . 1994;89:2552–2561
  55. Kauffman GJ , Boyne TS , Watson DD , et al.   Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction . J Am Coll Cardiol . 1996;27:1592–1597
  56. Medrano R , Lowry RW , Young JB , et al.   Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathologic study . Circulation . 1996;94:1010–1017
  57. Maes AF , Borgers M , Flameng W , et al.   Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT . J Am Coll Cardiol . 1997;29:62–68
  58. Siebelink HJ , Blanksma PK , Crijns HJGM , et al.   No difference in cardiac event-free survival between positron emission tomography-guided single-photon emission computed tomography-guided patient management . J Am Coll Cardiol . 2001;37:81–88
  59. Udelson JE . Testing our tests (Surrogate end points versus driving patient management and outcomes) . J Am Coll Cardiol . 2001;37:89–92
  60. Sharir T , Berman DS , Lewin HC , et al.   Incremental prognostic value of rest-redistribution 201Tl single-photon emission computed tomography . Circulation . 1999;100:1964–1970
  61. Dilsizian V , Rocco TP , Strauss HW , et al.   Technetium-99m isonitrile myocardial uptake at rest. I. Relation to severity of coronary artery stenosis . J Am Coll Cardiol . 1989;14:1673–1677
  62. Cohen MV , Sonnenblick EH , Kirk ES . Comparative effects of nitroglycerin and isosorbide dinitrate on coronary collateral vessels and ischemic myocardium in dogs . Am J Cardiol . 1976;37:244–249
  63. Aoki M , Sakai K , Koyanagi S , et al.   Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography . Am Heart J . 1991;121:1361–1366
  64. He Z-X , Darcourt J , Guigner A , et al.   Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT . J Nucl Med . 1993;34:1472–1477
  65. Bisi G , Sciagrà R , Santoro GM , et al.   Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates (feasibility and reliability for prediction of post-revascularization outcome of asynergic territories) . J Am Coll Cardiol . 1994;24:1282–1289
  66. Levine MG , McGill CC , Ahlberg AW , et al.   Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization . Am J Cardiol . 1999;83:1–5
  67. Iskandrian AE , Acio E . Methodology of a novel myocardial viability protocol . J Nucl Cardiol . 1998;5:206–209
  68. Travin MI , Herman SD , Wolinsky DG , et al.   Assessment of myocardial viability with gated SPECT Tc-99m sestamibi imaging during administration of sublingual nitroglycerin . J Nucl Med . 1995;36:56P; (abstract)
  69. Leoncini M , Marcucci G , Sciagrà R , et al.   Nitrate-enhanced gated technetium 99m sestamibi SPECT for evaluating regional wall motion at baseline and during low-dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction (comparison with two-dimensional echocardiography) . J Nucl Cardiol . 2000;7:426–431
  70. Matsunari I , Fujino S , Taki J , et al.   Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization (comparison with rest-redistribution thallium-201) . J Am Coll Cardiol . 1997;29:1226–1233
  71. Gunning MG , Anagnostopoulos C , Knight CJ , et al.   Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium . Circulation . 1998;98:1869–1874
  72. He W , Acampa W , Mainolfi C , et al.   Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction (relation to metabolic imaging by PET) . J Nucl Cardiol . 2003;10:599–606
  73. Stollfuss JC , Haas F , Matsunari I , et al.   99mTc-tetrofosmin SPECT for prediction of functional recovery defined by MRI in patients with severe left ventricular dysfunction (additional value of gated SPECT) . J Nucl Med . 1999;40:1824–1831
  74. Bergmann SR . Cardiac positron emission tomography . Semin Nucl Med . 1998;28:320–340
  75. Bergmann SR , Fox KAA , Rand AL , et al.   Quantification of regional myocardial blood flow in vivo with H215O . Circulation . 1984;70:724–733
  76. Bergmann SR . Quantification of myocardial perfusion with positron emission tomography . In:  Bergmann SR ,  Sobel BE editor. Positron Emission Tomography of the Heart . Mount Kisco, New York: Futura Publishing, Inc; 1992;p. 97–127
  77. Herrero P , Staudenherz A , Walsh JF , et al.   Heterogeneity of myocardial perfusion provides the physiological basis of perfusable tissue index . J Nucl Med . 1995;36:320–327
  78. Iida H , Rhodes CG , de Silva R , et al.   Myocardial tissue fraction–correction for partial volume effects and measure of tissue viability . J Nucl Med . 1991;32:2169–2175
  79. De Silva R , Yamamoto Y , Rhodes CG , et al.   Preoperative prediction of the outcome of coronary revascularization using positron emission tomography . Circulation . 1992;86:1738–1742
  80. Yamamoto Y , de Silva R , Rhodes CG , et al.   A new strategy for the assessment of viable myocardium and regional myocardial blood flow using 15O-water and dynamic positron emission tomography . Circulation . 1992;86:167–178
  81. Herrero P , Markham J , Shelton ME , et al.   Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography . Circ Res . 1992;70:496–507
  82. Gould KL , Yoshida K , Hess MJ , et al.   Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET . J Nucl Med . 1991;32:1–9
  83. Camici P , Ferrannini E , Opie LH . Myocardial metabolism in ischemic heart disease (Basic principles and application to imaging by positron emission tomography) . Prog Cardiovas Dis . 1989;32:217–238
  84. Lerch RA , Bergmann SR , Sobel BE . Delineation of myocardial fatty acid metabolism with positron emission tomography . In:  Bergmann SR ,  Sobel BE editor. Positron Emission Tomography of the Heart . Mount Kisco, New York: Futura Publishing, Inc; 1992;p. 129–152
  85. Tamaki N , Morita K , Tsukamoto E , Kawai Y . Future aspects of BMIPP . Int J Card Imaging . 1999;15:79–89
  86. Brunken RC , Mody FV , Hawkins RA , et al.   Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects . Circulation . 1992;86:1357–1369
  87. Rohatgi R , Epstein S , Henriquez J , et al.   Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction . Am J Cardiol . 2001;87:1096–1099
  88. Brunken RC , Kottou S , Nienaber CA , et al.   PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT . Radiology . 1989;172:65–73
  89. DiCarli MF , Asgarzadie F , Schelbert HR , et al.   Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy . Circulation . 1995;92:3436–3444
  90. Bonow RO . The hibernating myocardium (Implications for management of congestive heart failure) . Am J Cardiol . 1995;75:17A–25A
  91. Lee KS , Marwick TH , Cook SA , et al.   Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization . Circulation . 1994;90:2687–2694
  92. DiCarli MF , Davidson J , Little R , et al.   Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction . Am J Cardiol . 1994;73:527–533
  93. Eitzman D , Al-Aouar Z , Kanter HL , et al.   Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography . J Am Coll Cardiol . 1992;20:559–565
  94. Maddahi J , Blitz A , Phelps M , Laks H . The use of positron emission tomography imaging in the management of patients with ischemic cardiomyopathy . Adv Cardiol Surg . 1996;7:163–188
  95. Dreyfus GD , Duboc D , Blasco A , et al.   Myocardial viability assessment in ischemic cardiomyopathy (Benefits of coronary revascularization) . Ann Thorac Surg . 1994;57:1402–1408
  96. Akinboboye O , Idris O , Cannon P , et al.   Usefulness of positron emission tomography in defining myocardial viability in patients referred for cardiac transplantation . Am J Cardiol . 1999;83:1271–1274
  97. Bax JJ , Patton JA , Poldermans D , et al.   18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography (cardiac applications) . Semin Nucl Med . 2000;30:281–298
  98. Gropler RJ , Geltman EM , Sampathkumaran K , et al.   Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism . J Am Coll Cardiol . 1992;20:569–577
  99. Gropler RJ , Siegel BA , Sampathkumaran K , et al.   Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction . J Am Coll Cardiol . 1992;19:989–997
  100. Gropler RJ , Geltman EM , Sampathkumaran K , et al.   Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography . J Am Coll Cardiol . 1993;22:1587–1597
  101. Shelton ME , Dence CS , Hwang DR , et al.   Myocardial kinetics of fluorine-18 misonidazole (a marker of hypoxic myocardium) . J Nucl Med . 1989;30:351–358
  102. Shelton ME , Dence CS , Hwang D-R , et al.   In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography (a potential approach for identification of jeopardized myocardium) . J Am Coll Cardiol . 1990;16:477–485
  103. Hoffmann R , Lethen H , Marwick T , et al.   Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms . J Am Coll Cardiol . 1996;27:330–336
  104. Afridi I , Kleiman NS , Raizner AE , et al.   Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty . Circulation . 1995;91:663–670
  105. Cornel JH , Bax JJ , Elhendy A , et al.   Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease . J Am Coll Cardiol . 1998;31:1002–1010
  106. Afridi I , Grayburn PA , Panza JA , et al.   Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction . J Am Coll Cardiol . 1998;32:921–926
  107. Bonow RO . Identification of viable myocardium . Circulation . 1996;94:2674–2680
  108. Baumgartner H , Porenta G , Lau Y , et al.   Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT. Correlation with histopathology in explanted hearts . J Am Coll Cardiol . 1998;32:1701–1708
  109. Laddis T , Manning WJ , Danias PG , et al.   Cardiac MRI for assessment of myocardial perfusion (current status and future perspectives) . J Nucl Cardiol . 2001;8:207–214
  110. Kim RJ , Wu E , Rafael A , et al.   The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction . N Engl J Med . 2000;343:1445–1453
  111. Knuesel PR , Nanz D , Wyss C , et al.   Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance. Relation to functional outcome after revascularization . Circulation . 2003;108:1095–1100
  112. Schelbert HR . Assessment of myocardial viability with positron emission tomography . In:  Iskandrian AE ,  Van Der Wall EE editor. Myocardial Viability . ed 2. Dordrecht, Boston, London: Kluwer Academic Publishers; 2000;p. 47–72
  113. Samady H , Elefteriades JA , Abbott BG , et al.   Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome . Circulation . 1999;100:1298–1304
  114. Udelson JE . Steps forward in the assessment of myocardial viability in left ventricular dysfunction . Circulation . 1998;97:833–838
  115. Rahimtoola SH . Importance of diagnosing hibernating myocardium (how and in whom?) . J Am Coll Cardiol . 1997;30:1701–1706
  116. Cleland JG , Freemantle N , Ball SG , et al.   The heart failure revascularisation trial (HEART) (rationale, design and methodology) . Eur J Heart Fail . 2003;5:295–303
  117. Forrester JS , Price MJ , Makkar RR . Stem cell repair of infarcted myocardium. An overview for clinicians . Circulation . 2003;108:1139–1145
  118. Fam NP , Verma S , Kutryk M , et al.   Clinician guide to angiogenesis . Circulation . 2003;108:2613–2618

PII: S0001-2998(04)00060-1

doi: 10.1053/j.semnuclmed.2004.09.001

Seminars in Nuclear Medicine
Volume 35, Issue 1 , Pages 2-16 , January 2005

Article Tools

* Image Usage & Resolution